In February 2021, we provided an update on the guidance issued by the Therapeutic Goods Administration (TGA) regarding the advertising of COVID-19 vaccines to the Australian public. That update is available here: COVID-19 | TGA issues guidance for advertising of COVID-19 vaccines to Australian public.
Under the previous guidance, advertisers were restricted to republishing materials that were produced by Federal, State or Territory Governments, or were otherwise factual in nature (such as how to book an appointment, opening hours of vaccine clinics, etc). Under the new guidance, organisations and individuals may produce their own materials to promote COVID-19 vaccination to the general public, provided certain conditions are met.
The formal legal instruments enabling this guidance are:
This guidance will cease to have any effect on 31 December 2022. Ordinarily, direct to consumer advertising of prescription medicines and vaccines to the public is prohibited under Australian law. Advertising of medicines and vaccines to healthcare professionals is also regulated at law and by industry codes of conduct. The regulatory environment for medicines and vaccines promotion in Australia ensures public confidence in how prescribing decisions are made by physicians, and ensures that vulnerable patients are not misled.
The updated guidance allows any organisation (including the media, corporate entities or healthcare professionals) to create their own materials to promote COVID-19 vaccines, provided:
When preparing materials for use, organisations must remember that obligations under other laws, such as the Australian Consumer Law, continue to apply, such as the obligation not to mislead.
The TGA has also confirmed that organisations are permitted to offer valuable consideration (cash or other rewards) to people who have been fully vaccinated under the Government’s national COVID-19 vaccination program, provided the following conditions are met:
The offer can be made to a certain group, for example the employees of the business, or the members of the organisation, or to all members of the public.
If an offer is made via a competition or similar, it may constitute a trade promotion and additional State and Territory regulations may apply. Terms and conditions should be prepared, trade promotion permits may be required and specific wording may need to be included in advertising or promotional materials.
For clarity, the TGA has also provided guidance on what types of communications do not constitute ‘advertising’ for the purpose of the guidance. The TGA has confirmed that any party can publicly present factual and balanced information that is not promotional and therefore not subject to the advertising rules, about the COVID-19 vaccines.
The TGA has provided the following examples of what types of communications do not constitute advertising:
The TGA has also confirmed that the obligations of advertisers do not apply to discussions between a healthcare practitioner and their patient, in the course of a patient consultation, about the merits of COVID-19 vaccination or a particular vaccine. Clearly, such discussions constitute ‘medical advice’ and not promotion or advertising for the purpose of the prohibition on direct to consumer advertising. However, this guidance provides clarity for healthcare practitioners on how the regulator interprets the legislation.
Ordinarily, under Australian law, health professionals are not allowed to endorse a medicine or other therapeutic good.
However, the TGA has also confirmed that, in the context of the pandemic, this prohibition will not apply to registered COVID-19 vaccines.
The complete guidance is available at the TGA website: Communicating about COVID-19 vaccines | Therapeutic Goods Administration (TGA)
For details of all our COVID-19 tips and updates, visit the Gadens COVID-19 Hub.
If you found this insight article useful and you would like to subscribe to Gadens’ updates, click here.
Kelly Griffiths, Partner